X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com//news-release/2022/11/28/2562924/0/en/Farma-Mondo-Group-and-Helsinn-sign-exclusive-partnership-to-commercialize-AKYNZEO-in-the-Baltic-region.html
https://www.helsinn.com/news-and-events/helsinn-group-and-italfarmaco-announce-oral-presentation-of-nepa-netupitant-and-palonosetron-data-at-esmo-virtual-congress-2020/
https://www.globenewswire.com/news-release/2020/06/09/2045375/0/en/Helsinn-announces-launch-of-oral-formulation-of-Akynzeo-in-China.html#:~:text=Lugano%2C%20Switzerland%2C%20June%209%2C,has%20been%20launched%20in%20China.
https://health.economictimes.indiatimes.com/news/pharma/glenmark-expands-its-oncology-franchise-in-india-with-launch-of-helsinns-akynzeo/64939838
https://www.biospectrumasia.com/news/25/11263/glenmark-launches-helsinns-akynzeo-in-india.html
https://www.thepharmaletter.com/article/glenmark-gets-license-to-market-akynzeo-in-india
http://www.prnewswire.com/news-releases/helsinn-and-eisai-announce-revised-us-collaboration-for-cinv-franchise-300238039.html
http://www.pharmatimes.com/Article/16-01-12/Six_new_therapies_approved_for_NHS_Scotland.aspx
http://www.prnewswire.com/news-releases/helsinn-group-and-eisai-inc-announce-inclusion-of-akynzeo-netupitantpalonosetron-in-american-society-of-clinical-oncology-asco-antiemetics-guideline-update-300178090.html
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003728/WC500188435.pdf
http://www.pharmatimes.com/Article/15-03-29/Five_new_drugs_put_forward_for_approval_in_Europe.aspx
Market Place
Share 
